MUCUS D- guaifenesin, pseudoephedrine hydrochloride tablet 
L. Perrigo Company

----------

Perrigo Mucus D Drug Facts

Active ingredients (in each extended-release tablet)

Guaifenesin 600 mg

Pseudoephedrine HCl 60 mg

Purpose

Expectorant

Nasal Decongestant

Uses

•
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
•
temporarily relieves nasal congestion due to:
•
common cold
•
hay fever
•
upper respiratory allergies
•
temporarily restores freer breathing through the nose
•
promotes nasal and/or sinus drainage
•
temporarily relieves sinus congestion and pressure

Warnings

Do not use if you are

now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

•
heart disease
•
high blood pressure
•
thyroid disease
•
diabetes
•
trouble urinating due to an enlarged prostate gland
•
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
•
cough accompanied by too much phlegm (mucus)

When using this product

•
do not use more than directed

Stop use and ask a doctor if

•
you get nervous, dizzy, or sleepless
•
symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

•
do not crush, chew, or break tablet
•
take with a full glass of water
•
this product can be administered without regard for timing of meals
•
adults and children 12 years and older: 2 tablets every 12 hours; not more than 4 tablets in 24 hours
•
children under 12 years of age: do not use

Other information

•
store between 20-25°C (68-77°F)
•
do not use if blister unit is broken or torn

Inactive ingredients

colloidal silicon dioxide, copovidone, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, sodium starch glycolate, stearic acid

Questions or comments?

1-800-719-9260

Package/Label Principal Display Panel

Compare to Mucinex® D active ingredients

Mucus – D

Guaifenesin 600 mg / Pseudoephedrine Hydrochloride 60 mg Extended-Release Tablets

EXPECTORANT / NASAL DECONGESTANT

Clears Nasal / Sinus Congestion

Thins and Loosens Mucus

12 Hour

18 EXTENDED-RELEASE TABLETS

Perrigo Mucus D image 1
Perrigo Mucus D image 2
MUCUS D 
guaifenesin, pseudoephedrine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0113-2002
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN600 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
COPOVIDONE K25-31 (UNII: D9C330MD8B)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
Product Characteristics
ColorORANGE (peach) Scoreno score
ShapeOVAL (biconvex) Size18mm
FlavorImprint Code 600;Watson
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0113-2002-8918 in 1 CARTON03/02/201603/02/2016
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:0113-2002-6836 in 1 CARTON03/02/201603/02/2016
21 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09107103/02/201603/02/2016
Labeler - L. Perrigo Company (006013346)

Revised: 9/2022
 
L. Perrigo Company